Baicalin lipid nanocapsules for treatment of glioma: characterization, mechanistic cytotoxicity, and pharmacokinetic evaluation.
Alaa IbrahimSara A Abdel GaberMohamed Fawzi KabilOmar A H Ahmed-FaridAnna Katharina Herta HirschIbrahim M El-SherbinyMaha NasrPublished in: Expert opinion on drug delivery (2022)
Baicalin LNCs is a promising treatment modality for glioma, when administered through intravenous or intranasal routes.